TBPH Eran Broshy sells $590K worth of shares
Dec 02, 2025, 5:34 AM
0.00%
What does TBPH do
Theravance Biopharma, based in Grand Cayman, focuses on developing respiratory medicines and has 99 employees; its key product, YUPELRI, treats COPD. The company is also developing Ampreloxetine for neurogenic orthostatic hypotension and TD-8954 for gastrointestinal motility disorders.
Eran Broshy sold 29,501 shares of TBPH on 26 November at $20.00 per share, worth a total of $590K. They now own 60,204 TBPH shares, or a 40% holding decrease.
📡️ Health Care
Insider Trades
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.